Genetic syndromes associated with adrenal tumors

Adrenal Glands: Diagnostic Aspects and Surgical Therapy

Volumn , Issue , 2005, Pages 251-264

  Åkerström, Göran ^a   Hellman, Per ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349877798     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-540-26861-8_25     Document Type: Chapter

References (98)

1. Arlt W, Callies F, van Vlijmen JC, et al (1999) Dehy-droepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341:1013-1020
2. Astuti D, Douglas F, Lennard TWJ, et al (2001) Germline SDHD mutation in familial phaeochromocytoma. Lancet 357:1181-1182
3. Astuti D, Latif F, Dallol A., et al (2001) Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 69:49-54
4. Baghai M, Thompson GB, Young W.F., et al (2002) Pheo-chromocytomas and paragangliomas in von Hippel-Lin-dau disease. A role for laparoscopic and cortical-sparing surgery. Arch Surg 137:682-689
5. Baysal BE (2002) Hereditary paraganglioma targets diverse paraganglia. J Med Genet 39:617-622
6. Baysal BE, Ferrell RE, Willett-Brozick JE, et al (2000) Mutations in SDHD, a mitochondrial complex II gene in hereditary paraganglioma. Science 287:848-851
7. Baysal BE, Rubinstein WS, Taschner PEM (2001) Pheno-typic dichotomy in mitochondrial complex II genetic disorders. J Mol Med 79:495-503
8. Beckwith JB (1969) Macroglossia, omphalocoele, adrenal cytomegaly, gigantism and hyperplastic visceromegaly. Birth Defects 5:188-196
9. Benn DE, Croxson MS, Tucker K, et al (2003) Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas. Oncogene 22:1358-1364
10. Brauch H, Hoppner W, Jahnig H., et al (1997) Sporadic pheochromocytomas are rarely associated with germline mutations in the VHL tumor suppressor gene or the RET protooncogene. J Clin Endocrinol Metab 82:4101-4104
11. Brunt LM, Doherty GM, Norton J.A., et al (1996) Laparoscopic adrenalectomy compared to open adrenalectomy for benign adrenal neoplasms. J Am Coll Surg 183:1-10
12. Brunt LM, Lairmore TC, Doherty G.M., et al (2001) Adrenalectomy for familial pheochromocytoma in the laparoscopic era. Ann Surg 235:713-721
13. Burgess JR, Harle RA, Tucker P, et al (1996) Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Arch Surg 131:699-702
14. Burke AP, Sobin LH, Shekitka K.M., et al (1990) Somato-statin-producing duodenal carcinoids in patients with von Recklinghausen's neurofibromatosis. A predilection for black patients. Cancer 65:1591-1595
15. Cance WG, Wells SA Jr (1985) Multiple endocrine neoplasia type IIa. Curr Probl Surg 22:1-56
16. Carlson KM, Dou S, Chi D., et al (1994) Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 91: 1579-1583
17. Carney JA, Sizemore GW, Sheps S.G. (1976) Adrenal medullary disease in multiple endocrine neoplasia type 2: pheochromocytoma and its precursors. Am J Clin Pathol 66:279-290
18. Carney JA, Sizemore GW, Tyce G.M. (1975) Bilateral adrenal medullary hyperplasia in multiple endocrine neoplasia, type 2: the precursor of bilateral pheochromocytoma. Mayo Clin Proc 50:3-10
19. Casanova S, Rosenberg-Bourgin M, Farkas D., et al (1993) Phaeochromocytoma in multiple endocrine neoplasia type 2A: survey of 100 cases. Clin Endocrinol 38:531-537
20. Chew SL (2001) Paraganglioma genes. Clin Endocrinol 54:573-574
21. Couch V, Lindor NM, Karnes P.S., et al (2000) von Hippel-Lindau disease. Mayo Clin Proc 75:265-272
22. Donis-Keller H., Dou S, Chi D., et al (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2:851-856
23. Easton DF, Ponder MA, Cummings T, et al (1989) The clinical and screening age-at-onset distribution for the MEN-2 syndrome. Am J Hum Genet 44:208-215
24. Eisenhofer G, Lenders JW, Linehan W.M., et al (1999) Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med 340: 1872-1879
25. Eng C, Crossey PA, Mulligan L.M., et al (1995) Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumor suppressor gene in sporadic and syndromic pheochromocytomas. J Med Genet 32:934-937
26. Farndon JR, Leight GS, Dilley W.G., et al (1986) Familial medullary thyroid carcinoma without associated en-docrinopathies: a distinct clinical entity. Br J Surg 73: 278-281
27. Friedman JM, Birch P.H. (1997) Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1, 728 patients. Am J Med Genet 70:138-143
28. Friedrich CA (1999) Von Hippel-Lindau syndrome. A pleomorphic condition. Cancer 86:2478-2482
29. Friedrich CA (2001) Genotype-phenotype correlation in von Hippel-Lindau syndrome. Hum Mol Genet 10: 763-767
30. Gagner M, Lacroix A, Bolte E. (1992) Laparoscopic adrenalectomy in Cushing's syndrome and pheochromocytoma. N Engl J Med 327:1033
31. Gimm O, Armanios M, Dziema H., et al (2000) Somatic and occult germline mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. Cancer Res 60:6822-6825
32. Gutmann DH, Aylsworth A, Carey J.C., et al (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51-57
33. Hamilton BP, Landsberg L, Levine R.J. (1978) Measurement of urinary epinephrine in screening for pheochromocytoma in multiple endocrine neoplasia type II. Am J Med 65:1027-1032
34. Hansford JR, Mulligan L.M. (2000) Multiple endocrine neoplasia type 2 (MEN 2) and RET: from neoplasia to neurogenesis. J Med Genet 37:817-827
35. Harrington JL, Farley DR, van Heerden JA, et al (1999) Adrenal tumors and pregnancy. World J Surg 23:182-186
36. Henry I, Bonaiti-Pellie C, Chehensse V., et al (1991) Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature 351:665-667
37. Hofstra RM, Landsvater RM, Ceccherini I, et al (1994) A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367:375-376
38. Howe JR, Norton JA, Wells SA Jr (1993) Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term follow-up. Surgery 114:1070-1077
39. Inabnet W, Caragliano P, Pertsemlidis D. (2000) Pheochromocytoma: inherited associations, bilaterality, and cortex preservation. Surgery 128:1007-1012
40. Janetschek G, Finkenstedt G, Gasser R., et al (1998) Laparoscopic partial adrenalectomy in patients with hereditary forms of pheochromocytoma. J Urol 164:14-17
41. Jhiang SM (2000) The RET protooncogene in human cancers. Oncogene 19:5590-5597
42. Kapur BM, Sarin SK, Anand C.S., et al (1983) Carcinoid tumour of ampulla of Vater associated with viscero-cuta-neous neurofibromatosis. Postgrad Med 59:734-735
43. Khan TS, Sundin A, Juhlin C., et al (2003) 11C-metomidate PET imaging of adrenocortical cancer. Eur J Nucl Med Mol Imaging 30:403-410
44. Kikumori T, Evans D, Lee J.E., et al (2001) Genetic abnormalities in multiple endocrine neoplasia type 2. In: Doherty GM, Skogseid B (eds) Surgical endocrinology. Lippincott Williams & Wilkins, Philadelphia, pp 531-540
45. Kirschner LS, Carney JA, Pack S.D., et al (2000) Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 26:89-92
46. Koch CA, Vortmeyer AO, Huang S.C., et al (2001) Genetic aspects of pheochromocytoma. Endocr Regul 35:43-52
47. Koch C, Mauro D, McClellan M.W., et al (2002) Pheochromocytoma in von Hippel-Lindau disease: distinct histopathologic phenotype compared to pheochromo cytoma in multiple endocrine neoplasia type 2. Endocrine Pathol 13:17-27
48. Kopf D, Bockisch A, Steinert H., et al (1997) Octreotide scintigraphy and catecholamine response to an octreotide challenge in malignant phaeochromocytoma. Clin Endocrinol 46:39-44
49. Korf BR (2000) Malignancy in neurofibromatosis type 1. The Oncologist 5:477-485
50. Lairmore TC, Ball DW, Baylin S.B., et al (1993) Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes. Ann Surg 217: 595-603
51. Lee JE, Curley SA, Gagel R.F., et al (1996) Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma. Surgery 120:1064-1071
52. Li FP, Fraumeni J.F. (1969) Soft-tissue sarcomas, breast cancer, and other neoplasms: a familial syndrome? Ann Int Med 71:747-752
53. Lips KJ, Van der Sluys Veer J, Struyvenberg A, et al. (1981) Bilateral occurrence of pheochromocytoma in patients with the multiple endocrine neoplasia syndrome type 2A (Sipple's syndrome). Am J Med 70:1051-1060
54. Maher ER, Iselius L, Yates J.R., et al (1991) Von Hippel-Lindau disease: a genetic study. J Med Genet 28:443-447
55. Malkin D, Jolly KW, Barbier N, et al (1992) Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med 326:1309-1315
56. Marchesa P, Fazio VW, Church J.M., et al (1997) Adrenal masses in patients with familial adenomatous polyposis. Dis Colon Rectum 40:1023-1028
57. Modigliani E, Vasen HM, Raue K, et al (1995) Pheochromocytoma in multiple endocrine neoplasia type 2: European study. J Internal Med 238:363-367
58. Moley JF, Albinson C. (2001) Medullary thyroid carcinoma and the multiple endocrine neoplasia type 2 syndromes. In: Doherty GM, Skogseid B (eds) Surgical endocrinology. Lippincott Williams & Wilkins, Philadelphia, pp 541-557
59. Mulligan LM, Kwok JB, Healey C.S., et al (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460
60. Nakamura H, Koga M, Higa S., et al (1987) A case of von Recklinghausen's disease associated with pheochromo-cytoma and papillary carcinoma of the thyroid gland. Endocrinol Jpn 34:545-551
61. Neumann HPH, Berger DP, Sigmund G, et al (1993) Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med 329:1531-1538.
62. Erratum (1994) N Engl J Med 331: 1535
63. Neumann HPH, Eng C, Mulligan L.M., et al (1995) Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia type 2. JAMA 274:1149-1151
64. Neumann HPH, Bender BU, Reincke M, et al (1999) Adrenal-sparing surgery for phaeochromocytoma. Br J Surg 86:94-97
65. Neumann HPH, Bausch B, McWhinney S.R., et al (2002) Germ-line mutations in nonsyndromic pheochromocy-toma. N Engl J Med 346:1459-1466
66. Neumann HPH, Hoegerle S, Manz T., et al (2002) How many pathways to pheochromocytoma? Semin Nephrol 22:89-99
67. Nguyen L, Niccoli-Sire P, Caron P., et al (2001) Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study. Eur J Endocrinol 144:37-44
68. Niemann S, Müller U (2000) Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 26:268-270
69. O'Riordain D.S., O'Brien T, Crotty TB, et al (1995) Multiple endocrine neoplasia type 2B: more than an endocrine disorder. Surgery 118:936-942
70. Park VM, Pivnick E.K. (1998) Neurofibromatosis type 1 (NF1): A protein truncation assay yielding identification of mutations in 73% of patients. J Med Genet 35:813-820
71. Pomares FJ, Canas R, Rodriguez J.M., et al (1998) Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma. Clin Endocrinol 48:195-200
72. Ponder BA (1992) Neurofibromatosis: from gene to phe-notype. Semin Cancer Biol 3:115-120
73. Richard S, Beigelman C, Duclos J.M., et al (1994) Pheochromocytoma as the first manifestation of von Hippel-Lindau disease. Surgery 116:1076-1081
74. Shulkin BL, Wieland DM, Schwaiger M, et al (1992) PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. J Nucl Med 33: 1125-1131
75. Sims KB (2001) Von Hippel-Lindau disease: gene to bedside. Curr Opin Neurol 14:695-703
76. Sipple JH (1961) The association of pheochromocytoma with carcinoma of the thyroid gland. Am J Med 31:163-166
77. Sisson JC, Frager MS, Valk T.W., et al (1981) Scintigraphic localization of pheochromocytoma. N Engl J Med 305: 12-17
78. Skogseid B, Larsson C, Lindgren P.G., et al (1992) Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 75:76-81
79. Skogseid B, Rastad J, Gobl A., et al (1995) Adrenal lesion in multiple endocrine neoplasia type 1. Surgery 118: 1077-1082
80. Sköldberg F., Grimelius L, Woodward E.R., et al (1998) A family with hereditary extra-adrenal paragangliomas without evidence for mutations in the von Hippel-Lindau disease or ret genes. Clin Endocrinol 48:11-16
81. Srivastava S, Zou Z, Pirollo K., et al (1990) Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348:747-749
82. Stratakis CA (2001) Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes. J Endocrinol Invest 24:370-383
83. Stratakis CA, Kirschner LS, Carney J.A. (2001) Genetics of endocrine disease. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 86:4041-4046
84. Taymans SE, Macrae CA, Casey M, et al (1997) A refined genetic, radiation hybrid, and physical map of the Carney complex (CNC) locus on chromosome 2p16; evidence for genetic heterogeneity in the syndrome. Am J Hum Genet 61 Suppl A84.
85. Tenenbaum F, Lumbroso J, Schlumberger M., et al (1995) Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. J Nucl Med 36:1-6
86. Thompson GB, Grant CS, van Heerden JA, et al (1997) Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients. Surgery 122:1132-1136
87. Tibblin S, Dymling JF, Ingemansson S, et al (1983) Unilateral versus bilateral adrenalectomy in multiple endocrine neoplasia IIA. World J Surg 7:201-208
88. van Heerden J.A., Sizemore GW, Carney J.A., et al (1984) Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome. World J Surg 8:612-621
89. van Heerden J.A., Sizemore GW, Carney J.A., et al (1985) Bilateral subtotal adrenal resection for bilateral pheochromocytomas in multiple endocrine neoplasia, type IIa: a case report. Surgery 98:363-365
90. Wagner J, Portwine C, Rabin K., et al (1994) High frequency of germline p53 mutations in childhood adrenocortical cancer. J Natl Cancer Inst 86:1707-1710
91. Walther MM, Herring J, Enquist E., et al (1999) Von Recklinghausen's disease and pheochromocytomas. J Urol 162:1582-1586
92. Walther MM, Reiter R, Keiser H.R., et al (1999) Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. J Urol 162:659-664
93. Walther MM, Herring J, Choyke P.L., et al (2000) Laparoscopic partial adrenalectomy in patients with hereditary forms of pheochromocytoma. J Urol 164:14-17
94. Walther MM, Linehan WM, Libutti S.K. (2001) von Hippel-Lindau disease and von Recklinghausen's disease. In: Doherty GM, Skogseid B (eds) Surgical endocrinology. Lip-pincott Williams & Wilkins, Philadelphia, pp 581-591
95. Walther MM (2002) New therapeutic and surgical approaches for sporadic and hereditary pheochromocy-toma. Ann N Y Acad Sci 970:41-53
96. Walz MK, Peitgen K, Saller B., et al (1998) Subtotal adrenalectomy by the posterior retroperitoneoscopic approach. World J Surg 22:621-627
97. Wheeler MH, Curley IR, Williams E.D. (1986) The association of neurofibromatosis, pheochromocytoma, and somatostatinrich duodenal carcinoid tumor. Surgery 100: 1163-1169
98. Wiedemann HR (1964) Complex malformatif familial avec hernie ombilicale et macroglossie-un syndrome nouveau? J Genet Hum 13:223-232